M.G.G. Kier

687 total citations
17 papers, 442 citations indexed

About

M.G.G. Kier is a scholar working on Surgery, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, M.G.G. Kier has authored 17 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 11 papers in Molecular Biology and 6 papers in Reproductive Medicine. Recurrent topics in M.G.G. Kier's work include Testicular diseases and treatments (16 papers), Sexual Differentiation and Disorders (11 papers) and Ovarian cancer diagnosis and treatment (5 papers). M.G.G. Kier is often cited by papers focused on Testicular diseases and treatments (16 papers), Sexual Differentiation and Disorders (11 papers) and Ovarian cancer diagnosis and treatment (5 papers). M.G.G. Kier collaborates with scholars based in Denmark. M.G.G. Kier's co-authors include Jakob Lauritsen, Gedske Daugaard, Mette Saksø Mortensen, Mikkel Bandak, Mads Agerbæk, Niels V. Holm, Merete Kjær Hansen, Klaus Kaae Andersen, Niels Jørgensen and Susanne Oksbjerg Dalton and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

M.G.G. Kier

17 papers receiving 441 citations

Peers

M.G.G. Kier

SURGE

PRM

RHEUM

Mette Saksø Mortensen Denmark

Hink Boer Netherlands

Carsten Rusner Germany

Calogero Virgone Italy

Philip Pollock United Kingdom

Emre Tüzel Türkiye

Wendy Ansell United Kingdom

O. Klepp Norway

Helene F. S. Negaard Norway

Igal Silber United States

Mette Saksø Mortensen Denmark

M.G.G. Kier

586 ×1.6

SURGE

266 ×1.8

238 ×1.6

171 ×1.6

PRM

180 ×2.2

RHEUM

Citations per year, relative to M.G.G. Kier M.G.G. Kier (= 1×) peers Mette Saksø Mortensen

Countries citing papers authored by M.G.G. Kier

Since Specialization

Citations

This map shows the geographic impact of M.G.G. Kier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.G.G. Kier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.G.G. Kier more than expected).

Fields of papers citing papers by M.G.G. Kier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.G.G. Kier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.G.G. Kier. The network helps show where M.G.G. Kier may publish in the future.

Co-authorship network of co-authors of M.G.G. Kier

This figure shows the co-authorship network connecting the top 25 collaborators of M.G.G. Kier. A scholar is included among the top collaborators of M.G.G. Kier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.G.G. Kier. M.G.G. Kier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Lauritsen, Jakob, Merete Kjær Hansen, Mikkel Bandak, et al.. (2019). Cardiovascular Risk Factors and Disease After Male Germ Cell Cancer. Journal of Clinical Oncology. 38(6). 584–592. 50 indexed citations

Frederiksen, Peder, Jakob Lauritsen, Mikkel Bandak, et al.. (2017). Relapse and Mortality Risk of Stage I Testicular Cancer. PubMed. 47(2). 114–124. 3 indexed citations

Bandak, Mikkel, Niels Jørgensen, Anders Juul, et al.. (2017). Reproductive hormones and metabolic syndrome in 24 testicular cancer survivors and their biological brothers. Andrology. 5(4). 718–724. 5 indexed citations

Nayan, Madhur, Gedske Daugaard, Michael Jewett, et al.. (2017). PD53-07 CONDITIONAL RISK OF RELAPSE IN 3,601 PATIENTS MANAGED WITH SURVEILLANCE FOR STAGE I TESTICULAR CANCER. The Journal of Urology. 197(4S). 1 indexed citations

Bandak, Mikkel, Niels Jørgensen, Anders Juul, et al.. (2016). Preorchiectomy Leydig Cell Dysfunction in Patients With Testicular Cancer. Clinical Genitourinary Cancer. 15(1). e37–e43. 14 indexed citations

Kier, M.G.G., Jakob Lauritsen, Mette Saksø Mortensen, et al.. (2016). Prognostic Factors and Treatment Results After Bleomycin, Etoposide, and Cisplatin in Germ Cell Cancer: A Population-based Study. European Urology. 71(2). 290–298. 46 indexed citations

Mortensen, Mette Saksø, Jakob Lauritsen, M.G.G. Kier, et al.. (2016). Late Relapses in Stage I Testicular Cancer Patients on Surveillance. European Urology. 70(2). 365–371. 31 indexed citations

Daugaard, Gedske, M.G.G. Kier, Mikkel Bandak, et al.. (2016). The Danish Testicular Cancer database. Clinical Epidemiology. Volume 8. 703–707. 21 indexed citations

Bandak, Mikkel, Niels Jørgensen, Anders Juul, et al.. (2016). Testosterone deficiency in testicular cancer survivors – a systematic review and meta‐analysis. Andrology. 4(3). 382–388. 49 indexed citations

10.

Bandak, Mikkel, Niels Jørgensen, Anders Juul, et al.. (2016). Longitudinal Changes in Serum Levels of Testosterone and Luteinizing Hormone in Testicular Cancer Patients after Orchiectomy Alone or Bleomycin, Etoposide, and Cisplatin. European Urology Focus. 4(4). 591–598. 24 indexed citations

11.

Kier, M.G.G., Merete Kjær Hansen, Jakob Lauritsen, et al.. (2016). Second Malignant Neoplasms and Cause of Death in Patients With Germ Cell Cancer. JAMA Oncology. 2(12). 1624–1624. 62 indexed citations

12.

Lauritsen, Jakob, M.G.G. Kier, Mikkel Bandak, et al.. (2016). Pulmonary Function in Patients With Germ Cell Cancer Treated With Bleomycin, Etoposide, and Cisplatin. Journal of Clinical Oncology. 34(13). 1492–1499. 40 indexed citations

13.

Mortensen, Mette Saksø, Mikkel Bandak, M.G.G. Kier, et al.. (2016). Surveillance versus adjuvant radiotherapy for patients with high‐risk stage I seminoma. Cancer. 123(7). 1212–1218. 28 indexed citations

14.

Lauritsen, Jakob, M.G.G. Kier, Mette Saksø Mortensen, et al.. (2015). Germ cell cancer and multiple relapses: Toxicity and survival.. Journal of Clinical Oncology. 33(15_suppl). 4533–4533. 1 indexed citations

15.

Lauritsen, Jakob, M.G.G. Kier, Mette Saksø Mortensen, et al.. (2015). Germ Cell Cancer and Multiple Relapses: Toxicity and Survival. Journal of Clinical Oncology. 33(28). 3116–3123. 22 indexed citations

16.

Lauritsen, Jakob, Mette Saksø Mortensen, M.G.G. Kier, et al.. (2014). Renal impairment and late toxicity in germ-cell cancer survivors. Annals of Oncology. 26(1). 173–178. 26 indexed citations

17.

Kier, M.G.G., Jakob Lauritsen, Kristian Almstrup, et al.. (2014). Screening for carcinomain situ in the contralateral testicle in patients with testicular cancer: a population-based study. Annals of Oncology. 26(4). 737–742. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact